CD79A and autoimmune disease: A recent study aiming to clarify the mechanisms of autoantibody formation in CD demonstrated that IgA-switched TG2-specific B cells are uniquely present in untreated patients and are distinct from those observed in autoimmune diseases—most notably SLE—and in particular chronic infectious diseases [35].